The estimated Net Worth of Christopher Paige is at least $1.41 millió dollars as of 11 February 2020. Christopher Paige owns over 15,000 units of AvroBio Inc stock worth over $353,517 and over the last 6 years he sold AVRO stock worth over $907,200. In addition, he makes $145,303 as Independent Director at AvroBio Inc.
Christopher has made over 3 trades of the AvroBio Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 15,000 units of AVRO stock worth $420,000 on 11 February 2020.
The largest trade he's ever made was selling 15,000 units of AvroBio Inc stock on 11 February 2020 worth over $420,000. On average, Christopher trades about 4,375 units every 39 days since 2019. As of 11 February 2020 he still owns at least 252,512 units of AvroBio Inc stock.
You can see the complete history of Christopher Paige stock trades at the bottom of the page.
Dr. Christopher Paige, Ph.D., serves as Independent Director of the Company. Dr. Paige is a senior scientist at University Health Network and a professor in the departments of medical biophysics and immunology at the University of Toronto, and has served in such roles since 1987. From 1997 to October 2016, he served as the vice president, research of the University Health Network. In 1990, Dr. Paige became the founding director of the Arthritis and Autoimmunity Research Centre as well as director of research at The Wellesley Hospital. He became a member of the Basel Institute for Immunology in Switzerland in 1980 where he worked until joining the Ontario Cancer Institute as a senior scientist in 1987. Dr. Paige also has experience serving on the board of directors of privately held companies. Dr. Paige earned a B.S. in biology at the University of Notre Dame in 1974 and a Ph.D. in immunology at the Sloan-Kettering Division of Cornell University Graduate School of Medical Sciences in 1979.
As the Independent Director of AvroBio Inc, the total compensation of Christopher Paige at AvroBio Inc is $145,303. There are 10 executives at AvroBio Inc getting paid more, with Birgitte Volck having the highest compensation of $4,384,270.
Christopher Paige is 67, he's been the Independent Director of AvroBio Inc since 2016. There are no older and 20 younger executives at AvroBio Inc.
Christopher's mailing address filed with the SEC is C/O AVROBIO, INC., 100 TECHNOLOGY SQUARE, 6TH FLOOR, CAMBRIDGE, MA, 02139.
Over the last 6 years, insiders at AvroBio Inc have traded over $3,066,308 worth of AvroBio Inc stock and bought 2,395,057 units worth $31,037,133 . The most active insiders traders include Braden Michael Leonard, Bruce Booth és Venture Fund X, L.P.Atlas V.... On average, AvroBio Inc executives and independent directors trade stock every 102 days with the average trade being worth of $206,675. The most recent stock trade was executed by Braden Michael Leonard on 13 May 2024, trading 766,635 units of AVRO stock currently worth $973,626.
clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare disease.
AvroBio Inc executives and other stock owners filed with the SEC include: